VJHemOnc is committed to improving our service to you

SOHO 2020 | R/R lymphoma: checkpoint blockade and transplantation

VJHemOnc is committed to improving our service to you

David J. Straus

David J. Straus, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, explores treatments for relapsed/refractory Hodgkins lymphoma, including nivolumab and pembrolizumab as well as ongoing studies evaluating CAR-T therapies in this patient population. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter